IP Library Granted Patent US 12,198,814
Granted Patent B2
US 12,198,814 · App. 17/966,723 · Granted Jan 14, 2025

Tracking infectious disease using a comprehensive clinical risk profile and performing actions in real-time via a clinic portal

Inventors: Nathan Gnanasambandam (Irvine, CA); Mark Henry Anderson (Newport Coast, CA)
Assignee: HEALTHPOINTE SOLUTIONS, INC.
G16H50/30G16H10/60G16H40/20G16H50/20G16H50/80G16H10/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,198,814
App. No.
17/966,723
Granted
Jan 14, 2025
Kind
B2
Abstract

A method for determining a risk for an infectious disease for a patient using a cognitive intelligence platform is disclosed. The method includes receiving, from an authoritative source, factors indicative of a person being infected by the infectious disease, wherein the factors include medical information pertaining to the infectious disease. The method also includes determining whether any of the factors are present in a patient graph of the patient, wherein the patient graph includes medical information pertaining to the patient and the determining is performed by matching the medical information pertaining to the infectious disease to the medical information pertaining to the patient. The method also includes, responsive to determining the factors are present in the patient graph of the patient, determining the risk for the infectious disease for the patient, and performing a preventative action based on the risk for the infectious disease.

Claims (75)

1. A method for determining a risk for an infectious disease for a patient using a cognitive intelligence platform:

receiving, from an authoritative source, factors indicative of a person being infected by the infectious disease, wherein the factors comprise medical information pertaining to the infectious disease, wherein the authoritative source comprises a plurality of medical doctors and weights for the factors are assigned and dynamically adjusted in real-time based on a certain percentage of the plurality of medical doctors agreeing the factors are indicative of being infected by the infectious disease or disagreeing the factors are indicative of being infected by the infectious disease;

determining whether any of the factors are present in a patient graph of the patient, wherein the patient graph comprises medical information pertaining to the patient and the determining is performed by matching the medical information pertaining to the infectious disease to the medical information pertaining to the patient;

responsive to determining the factors are present in the patient graph of the patient, determining the risk for the infectious disease for the patient;

performing a preventative action based on the risk for the infectious disease;

receiving, from a computing device of a patient, a symptom the patient is experiencing;

updating the patient graph to include the symptom in the medical information to obtain an updated patient graph;

determining whether any of the factors are present in the updated patient graph of the patient;

responsive to determining the factors are present in the updated patient graph of the patient, determining the risk for the infectious disease for the patient; and

performing the preventative action based on the risk for the infectious disease;

determining a plurality of risks for the infectious disease for a plurality of people in a geographic region;

recommending a supply of medical supplies to a certain area of the geographic region where a threshold number of people in the plurality of people have a threshold risk level of the plurality of risks.

2. The method of claim 1 , further comprising:

causing the risk for the infectious disease for the patient to be presented on a user interface of a computing device of a medical personnel;

causing a list of preventative actions to be presented on the user interface;

receiving, from the computing device of the medical personnel, a selection of the preventative action from the list of preventative actions.

3. The method of claim 1 , further comprising electronically performing the preventative action based on the risk for the infectious disease satisfying a threshold risk condition.

4. The method of claim 1 , wherein the preventative action comprises:

transmitting curated educational material pertaining to the infectious disease to a computing device of the patient;

transmitting contact information for a medical provider to the computing device of the patient;

causing a test kit for the infectious disease to be transmitted to a location of the patient;

coordinating retrieval of the test kit from the location of the patient;

initiating a telemedicine session between a computing device of a medical personnel and a computing device of a patient.

5. The method of claim 1 , wherein the authoritative source comprise a center for disease control, a regulative agency, or some combination thereof.

6. The method of claim 1 , wherein the medical information comprises a symptom of the person, a medical condition of the person, a medical procedure performed on the person, familial medical history of the person, or some combination thereof, and the factors further comprise:

an age of the person,

a gender of the person,

a number of confirmed cases of the infectious disease in a geographical location of the person,

a type of strain present in the geographical location of the person,

a travel profile of people in the geographical location of the person, or

some combination thereof.

7. The method of claim 1 , further comprising generating a comprehensive clinical risk profile for each of a plurality of patients, wherein the plurality of patients comprises the patient and the comprehensive clinical risk profile comprises the risk for the infectious disease, a risk for a medical condition that exacerbates effects of the infectious disease, a demographic risk, and a epidemiologic risk.

8. The method of claim 1 , further comprising providing an overview user interface to be presented on a computing device of a medical personnel, wherein the overview user interface comprises a geographical map of a region including graphical representations of densities of people and determined risks for the infectious disease of the densities of people.

9. The method of claim 1 , further comprising:

presenting an overview geographical map of a location of a plurality of hospitals;

receiving a selection of one of the plurality of hospitals as a selected hospital;

presenting information pertaining to the selected hospital, wherein the information comprises a number of available beds at the selected hospital, a number of available test kits for the infectious disease, a number of people confirmed as having the infectious disease, or some combination thereof.

10. A tangible, non-transitory computer-readable medium storing instructions that, when executed, cause a processing device to:

receive, from an authoritative source, factors indicative of a person being infected by the infectious disease, wherein the factors comprise medical information pertaining to the infectious disease, wherein the authoritative source comprises a plurality of medical doctors and weights for the factors are assigned and dynamically adjusted in real-time based on a certain percentage of the plurality of medical doctors agreeing the factors are indicative of being infected by the infectious disease or disagreeing the factors are indicative of being infected by the infectious disease;

determine whether any of the factors are present in a patient graph of the patient, wherein the patient graph comprises medical information pertaining to the patient and the determining is performed by matching the medical information pertaining to the infectious disease to the medical information pertaining to the patient;

responsive to determining the factors are present in the patient graph of the patient, determine the risk for the infectious disease for the patient;

perform a preventative action based on the risk for the infectious disease;

receive, from a computing device of a patient, a symptom the patient is experiencing;

updating the patient graph to include the symptom in the medical information to obtain an updated patient graph;

determine whether any of the factors are present in the updated patient graph of the patient;

responsive to determining the factors are present in the updated patient graph of the patient, determine the risk for the infectious disease for the patient; and

perform the preventative action based on the risk for the infectious disease;

determine a plurality of risks for the infectious disease for a plurality of people in a geographic region; and

recommend a supply of medical supplies to a certain area of the geographic region where a threshold number of people in the plurality of people have a threshold risk level of the plurality of risks.

11. The computer-readable medium of claim 10 , wherein the processing device is further to:

cause the risk for the infectious disease for the patient to be presented on a user interface of a computing device of a medical personnel;

cause a list of preventative actions to be presented on the user interface;

receive, from the computing device of the medical personnel, a selection of the preventative action from the list of preventative actions.

12. The computer-readable medium of claim 10 , wherein the processing device is further to electronically perform the preventative action based on the risk for the infectious disease satisfying a threshold risk condition.

13. The computer-readable medium of claim 10 , wherein the preventative action comprises:

transmitting curated educational material pertaining to the infectious disease to a computing device of the patient;

transmitting contact information for a medical provider to the computing device of the patient;

causing a test kit for the infectious disease to be transmitted to a location of the patient;

coordinating retrieval of the test kit from the location of the patient;

initiating a telemedicine session between a computing device of a medical personnel and a computing device of a patient.

14. The computer-readable medium of claim 10 , wherein the authoritative source comprise a center for disease control, a regulative agency, or some combination thereof.

15. A system comprising:

a memory device storing instructions;

a processing device communicatively coupled to the memory device, the processing device executes the instructions to:

receive, from an authoritative source, factors indicative of a person being infected by the infectious disease, wherein the factors comprise medical information pertaining to the infectious disease, wherein the authoritative source comprises a plurality of medical doctors and weights for the factors are assigned and dynamically adjusted in real-time based on a certain percentage of the plurality of medical doctors agreeing the factors are indicative of being infected by the infectious disease or disagreeing the factors are indicative of being infected by the infectious disease;

determine whether any of the factors are present in a patient graph of the patient, wherein the patient graph comprises medical information pertaining to the patient and the determining is performed by matching the medical information pertaining to the infectious disease to the medical information pertaining to the patient;

responsive to determining the factors are present in the patient graph of the patient, determine the risk for the infectious disease for the patient;

perform a preventative action based on the risk for the infectious disease;

receive, from a computing device of a patient, a symptom the patient is experiencing;

updating the patient graph to include the symptom in the medical information to obtain an updated patient graph;

determine whether any of the factors are present in the updated patient graph of the patient;

responsive to determining the factors are present in the updated patient graph of the patient, determine the risk for the infectious disease for the patient; and

perform the preventative action based on the risk for the infectious disease;

determine a plurality of risks for the infectious disease for a plurality of people in a geographic region; and

recommend a supply of medical supplies to a certain area of the geographic region where a threshold number of people in the plurality of people have a threshold risk level of the plurality of risks.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE US APPLICATION SERIAL NO. 17773254 SHOULD READ 17773251; US APPLICATION SERIAL NO. 16966723 SHOULD READ 17966723; AND US APPLICATION SERIAL NO. 17671604 SHOULD READ 17674604 PREVIOUSLY RECORDED ON REEL 67462 FRAME 689. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST. Recorded May 30, 2024
From: HEALTHPOINTE SOLUTIONS, INC.
To: HPS ADMIN LLC
Reel/Frame 067823/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 6, 2023
From: GNANASAMBANDAM, NATHAN; ANDERSON, MARK HENRY
To: HEALTHPOINTE SOLUTIONS, INC.
Reel/Frame 065783/0471 →
Continuity (2)
Provisional Application 63010586 · Apr 15, 2020
Related Publication 20230343460A1 · Oct 26, 2023
References Cited (67)
US 6687685B1 · Sadeghi · 2004 [cited by examiner]
US 7024399B2 · Sumner, II · 2006 [cited by examiner]
US 7376456B2 · Marshik-Geurts · 2008 [cited by examiner]
US 7689521B2 · Nodelman · 2010 [cited by examiner]
US 7813870B2 · Downs · 2010 [cited by examiner]
US 8521546B2 · Brown · 2013 [cited by examiner]
US 9147041B2 · Amarasingham · 2015 [cited by examiner]
US 9536052B2 · Amarasingham · 2017 [cited by examiner]
US 10496678B1 · Tang · 2019 [cited by examiner]
US 10755369B2 · Amarasingham · 2020 [cited by examiner]
US 10885150B2 · De La Torre · 2021 [cited by examiner]
US 10991053B2 · Pingali · 2021 [cited by examiner]
US 11410757B2 · Li · 2022 [cited by examiner]
US 11562257B2 · Stevens · 2023 [cited by examiner]
US 11636350B1 · Giannulli · 2023 [cited by examiner]
US 11657912B2 · Dunn · 2023 [cited by examiner]
US 11823798B2 · Allen · 2023 [cited by examiner]
US 11967428B1 · Boussios · 2024 [cited by examiner]
US 12061612B1 · Sager · 2024 [cited by examiner]
US 20020107707A1 · Naparstek · 2002 [cited by examiner]
US 20040039710A1 · McMillan · 2004 [cited by examiner]
US 20050240544A1 · Kil · 2005 [cited by examiner]
US 20060085230A1 · Brill · 2006 [cited by examiner]
US 20060129427A1 · Wennberg · 2006 [cited by examiner]
US 20090106004A1 · Edwards · 2009 [cited by examiner]
US 20110166883A1 · Palmer · 2011 [cited by examiner]
US 20120116850A1 · Abe · 2012 [cited by examiner]
US 20130159023A1 · Srinivas · 2013 [cited by examiner]
US 20130191153A1 · Lee · 2013 [cited by examiner]
US 20130262357A1 · Amarasingham · 2013 [cited by examiner]
US 20140074509A1 · Amarasingham · 2014 [cited by examiner]
US 20140149128A1 · Getchius · 2014 [cited by examiner]
US 20140167917A2 · Wallace et al. · 2014 [cited by applicant]
US 20140279754A1 · Barsoum · 2014 [cited by examiner]
US 20140343965A1 · Miyoshi · 2014 [cited by examiner]
US 20150012292A1 · Khan · 2015 [cited by applicant]
US 20150234981A1 · Naidich · 2015 [cited by applicant]
US 20160019666A1 · Amarasingham · 2016 [cited by examiner]
US 20160117322A1 · Ramaswamy · 2016 [cited by examiner]
US 20160203279A1 · Srinivas · 2016 [cited by examiner]
US 20160292304A1 · Kartha · 2016 [cited by examiner]
US 20170004279A1 · Pingali · 2017 [cited by examiner]
US 20170011131A1 · Li et al. · 2017 [cited by applicant]
US 20170061093A1 · Amarasingham · 2017 [cited by examiner]
US 20170124269A1 · McNair · 2017 [cited by examiner]
US 20170132371A1 · Amarasingham · 2017 [cited by examiner]
US 20170277841A1 · Shankar · 2017 [cited by examiner]
US 20170277857A1 · De La Torre · 2017 [cited by examiner]
US 20180004904A1 · Phillips · 2018 [cited by examiner]
US 20180166174A1 · Lewis · 2018 [cited by applicant]
US 20180181719A1 · Balian · 2018 [cited by examiner]
US 20180261309A1 · Vasiliu-Feltes · 2018 [cited by examiner]
US 20190130069A1 · Li · 2019 [cited by examiner]
US 20190139643A1 · Li · 2019 [cited by examiner]
US 20190304023A1 · Pingali · 2019 [cited by examiner]
US 20200402665A1 · Zhang · 2020 [cited by examiner]
US 20210118557A1 · Pauws · 2021 [cited by examiner]
US 20210158909A1 · Ng · 2021 [cited by examiner]
US 20220179880A1 · Ghalwash · 2022 [cited by examiner]
US 20220230095A1 · Stergioudis · 2022 [cited by examiner]
US 20230020908A1 · Drake · 2023 [cited by examiner]
US 20240120109A1 · Sahu · 2024 [cited by examiner]
US 20240145084A1 · Song · 2024 [cited by examiner]
CA 3235277A1 · 2003 [cited by examiner]
WO WO2016089914A1 · 2016 [cited by applicant]
Scott, Elsevier, 2021, pp. 1-8. [cited by examiner]
Li, Elsevier, 2020, pp. 1-10. [cited by examiner]